Literature DB >> 20877289

mTORC1 signaling in energy balance and metabolic disease.

C Catania1, E Binder, D Cota.   

Abstract

The mammalian target of rapamycin complex 1 (mTORC1) pathway regulates cellular responses to fuel availability. Recent studies have demonstrated that within the central nervous system, and in particular the hypothalamus, mTORC1 represents an essential intracellular target for the actions of hormones and nutrients on food intake and body weight regulation. By being at the crossroads of a nutrient-hormonal signaling network, mTORC1 also controls important functions in peripheral organs, such as muscle oxidative metabolism, white adipose tissue differentiation and β-cell-dependent insulin secretion. Notably, dysregulation of the mTORC1 pathway has been implicated in the development of obesity and obesity-related conditions, such as type 2 diabetes. This manuscript will therefore review recent progress made in understanding the role of the mTORC1 pathway in the regulation of energy balance and peripheral metabolism. Furthermore, we will critically discuss the potential relevance of this intracellular pathway as a therapeutic target for the treatment of metabolic disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20877289     DOI: 10.1038/ijo.2010.208

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  26 in total

Review 1.  Target acquired: Selective autophagy in cardiometabolic disease.

Authors:  Trent D Evans; Ismail Sergin; Xiangyu Zhang; Babak Razani
Journal:  Sci Signal       Date:  2017-02-28       Impact factor: 8.192

Review 2.  Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review.

Authors:  Peter Csermely; Tamás Korcsmáros; Huba J M Kiss; Gábor London; Ruth Nussinov
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

3.  Anorexic response to rapamycin does not appear to involve a central mechanism.

Authors:  Hale Z Toklu; Erin B Bruce; Yasemin Sakarya; Christy S Carter; Drake Morgan; Michael K Matheny; Nataliya Kirichenko; Philip J Scarpace; Nihal Tümer
Journal:  Clin Exp Pharmacol Physiol       Date:  2016-09       Impact factor: 2.557

Review 4.  mTOR couples cellular nutrient sensing to organismal metabolic homeostasis.

Authors:  Jessica J Howell; Brendan D Manning
Journal:  Trends Endocrinol Metab       Date:  2011-01-25       Impact factor: 12.015

5.  Rapamycin has age-, treatment paradigm-, and model-specific anticonvulsant effects and modulates neuropeptide Y expression in rats.

Authors:  Tamar Chachua; Ka-Lai Poon; Mi-Sun Yum; Leigh Nesheiwat; Kara DeSantis; Jana Velíšková; Libor Velíšek
Journal:  Epilepsia       Date:  2012-09-27       Impact factor: 5.864

Review 6.  Hypothalamic inflammation: a double-edged sword to nutritional diseases.

Authors:  Dongsheng Cai; Tiewen Liu
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

7.  Molecular characterization and functional analysis of Cashmere goat mammalian target of rapamycin.

Authors:  Yan Liang; Wen-Lei Bao; Chan-Chan Bao; Xiu-Fen Miao; Hui-Fang Hao; Shu-Yu Li; Zhi-Gang Wang; Dong-Jun Liu
Journal:  DNA Cell Biol       Date:  2011-12-16       Impact factor: 3.311

8.  Knockdown of PRAS40 inhibits insulin action via proteasome-mediated degradation of IRS1 in primary human skeletal muscle cells.

Authors:  C Wiza; D Herzfeld de Wiza; E B M Nascimento; S Lehr; H Al-Hasani; D M Ouwens
Journal:  Diabetologia       Date:  2013-03-05       Impact factor: 10.122

9.  In situ characterization of the mTORC1 during adipogenesis of human adult stem cells on chip.

Authors:  Xuanye Wu; Nils Schneider; Alina Platen; Indranil Mitra; Matthias Blazek; Roland Zengerle; Roland Schüle; Matthias Meier
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-05       Impact factor: 11.205

10.  Seeking mTORC1 Inhibitors Through Molecular Dynamics Simulation of Arginine Analogs Inhibiting CASTOR1.

Authors:  Liang Sun; Xinyu Li; Jun Pan; Jiashun Mao; Yueyang Yuan; Duoxi Wang; Weiwei Sun; Gerhard R F Krueger; Guanyu Wang
Journal:  Cancer Genomics Proteomics       Date:  2019 Nov-Dec       Impact factor: 4.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.